文献速递肺外科

Ⅰ期肺腺癌复发高危因素:JCOG0201随访数据

High-Risk Factors for Recurrence of Stage I Lung Adenocarcinoma: Follow-up Data From JCOG0201.
PubMed 文献 · Ann Thorac Surg · 2019-07-20

基于JCOG0201前瞻性多机构研究中536例接受肺叶切除的病理Ⅰ期肺腺癌患者,以浸润成分大小(排除贴壁成分)作为肿瘤大小,中位随访10.2年,全组10年无复发生存率为83.9%。多因素Cox分析显示年龄>65岁、浸润成分>2cm、脏层胸膜侵犯和血管侵犯为RFS的独立预后因素,具备任一危险因素的高危组复发风险显著高于低危组。

要点

  • 浸润成分>2cm、脏层胸膜侵犯或血管侵犯提示Ⅰ期肺腺癌复发高危。
  • 高危组(n=124)较低危组(n=408)RFS显著更差,HR为3.61。
  • 年龄>65岁亦为RFS的独立不良预后因素。

核心结论

  • 病理Ⅰ期肺腺癌中,浸润成分>2cm、脏层胸膜侵犯或血管侵犯者复发风险高。

研究设计与样本

  • JCOG0201前瞻性多机构研究资料回顾,纳入536例接受肺叶切除的病理Ⅰ期肺腺癌患者,中位随访10.2年。

主要发现

  • 全组10年RFS为83.9%。
  • 年龄>65岁HR 2.60(95%CI 1.66-4.07),浸润成分>2cm HR 2.70(95%CI 1.40-5.23)。
  • 脏层胸膜侵犯HR 2.17(95%CI 1.23-3.81),血管侵犯HR 2.59(95%CI 1.47-4.55)。
  • 高危组(n=124)较低危组(n=408)RFS的HR为3.61(95%CI 2.35-5.55)。

关键数值与推荐

  • 高危组定义:浸润成分>2cm或脏层胸膜侵犯阳性或血管侵犯阳性。
  • 低危组定义:浸润成分≤2cm且脏层胸膜侵犯和血管侵犯均阴性。

临床怎么用

  • 对病理Ⅰ期肺腺癌术后患者,可依据浸润成分大小、脏层胸膜侵犯和血管侵犯识别复发高危人群并加强随访。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The aim of this study was to identify patients with pathological stage I lung adenocarcinoma at high risk of recurrence. METHODS: We retrieved data from 536 patients with pathological stage I lung adenocarcinoma who underwent lobectomy and were enrolled in a prospective multiinstitutional study (the JCOG0201 study). Invasive component size, excluding lepidic component, was used as the tumor size. Recurrence-free survival (RFS) was estimated by the Kaplan-Meier method, and a multivariable Cox proportional hazards model identified independent prognostic factors associated with worse RFS. RESULTS: The all-patient 10-year RFS was 83.9% (median follow-up 10.2 years). Multivariable Cox analysis revealed that age greater than 65 years (hazard ratio [HR], 2.60; 95% confidence interval (CI), 1.66-4.07), invasive component size greater than 2 cm (HR, 2.70; 95% CI, 1.40-5.23), visceral pleural invasion (HR, 2.17; 95% CI, 1.23-3.81), and vascular invasion (HR, 2.59; 95% CI, 1.47-4.55) were potential independent prognostic factors for RFS. When patients were divided into a high-risk group for recurrence (invasive component size >2 cm or positive for visceral pleural invasion or for vascular invasion; n = 124) and a low-risk group (invasive component size ≤2 cm and negative for visceral pleural invasion and vascular invasion; n = 408), there was a significant difference in RFS between the high-risk and low-risk groups (high-risk group: HR, 3.61; 95% CI, 2.35-5.55). CONCLUSIONS: Pathological stage I lung adenocarcinoma patients with an invasive component size greater than 2 cm, visceral pleural invasion, or vascular invasion were at high risk for recurrence.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Tsutani Y, Suzuki K, Koike T, et al. High-Risk Factors for Recurrence of Stage I Lung Adenocarcinoma: Follow-up Data From JCOG0201. Ann Thorac Surg. 2019. PMID: 31336067. doi:10.1016/j.athoracsur.2019.05.080

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。